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The role of resident cells during the lipopolysac-
charide (LPS)-induced neutrophil recruitment
into rat air pouches was investigated. In this
model, LPS (Escherichia coli, O55: B5 strain; 2±
2000ng) induced a dose- and time-dependent
neutrophil recruitment accompanied by the gen-
eration of a tumour necrosis factor-a (TNFa)-like
activity. Dexamethasone (0.05±5 mg) and cyclo-
heximide (6 ng), injected 2 h before LPS into the
pouches, inhibited the neutrophil recruitment
and the generation of the TNFa-like activity, while
the H1-receptor antagonist mepyramine (1 and
4 mg/kg, i.p., 0.5 h before LPS) and the PAF-
receptor antagonist WEB 2170 (0.05 and 1 mg/kg,
i.p., 0.5 h before LPS) had no effect. Puri￿ ed
alveolar macrophages (AM) were used to replen-
ish the pouches of cycloheximide-treated recipi-
ent rats. AM provided by PBS-treated animals led
to the recovery of the LPS-induced neutrophil
recruitment and of the TNFa-like formation con-
trasting with those from cycloheximide-treated
animals (1 mg/kg, i.p.). When delivered in situ,
liposome-encapsulated clodronate, a macrophage
depletor, signi￿ cantly impaired both the LPS-
induced neutrophil recruitment and the TNFa-like
activity. An anti-murine TNFa polyclonal antibody
(0.5 h before LPS) was also effective. These results
emphasize the pivotal role of macrophages for
LPS-induced neutrophil recruitment via the for-
mation of TNFa.
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Introduction
Leukocyte recruitment1,2 and the formation of
pro-in￿ammatory mediators, including different
cytokines, are the hallmark of an in￿ammatory
response. The latter is characterized by vasodila-
tation, rapidly followed by neutrophil adhesion
to endothelium and migration into the perivas-
cular connective tissue.
In vitro studies have shown that the bacterial
endotoxin (lipopolysaccharide, LPS) is not by
itself a chemotactic factor,3 even though LPS
may interact with neutrophils via CD14 and the
LPS-binding protein (LBP) to express CR3 activ-
ity which mediates neutrophil adhesion.4,5 In
fact, local cell targets seem to be more relevant
in vivo and in particular, resident macrophages
are believed to play a pivotal role in the
recognition and the transduction of the effects
of LPS (for review, see Manthey and Vogel6)
since they produce the chemotactic mediators
IL-1a and b, TNFa, IL-8 and MIP-1 and 2 as well
as LTB4 and PAF . Furthermore, LPS elicits a
selective and transient cycloheximide-depen-
dent collagenase synthesis by macrophages,
providing thus another potential tissue dama-
ging factor.7
Initially described as a potent in￿ammatory
cytokine derived from LPS-activated macro-
phages, TNFa may also account for neutro-
penia, neutrophilia8,9 and neutrophil recruit-
ment2,10- 12 and activation.13,14 TNFa also in-
duces the expression of cell surface molecules,
leading to adherence on endothelial cells.15
As an early cytokine, TNFa is released extra-
cellularly within 15 min after its gene transcrip-
tion upon exposure to in￿ammatory stimuli.16
Its broad spectrum of activities and the amounts
produced by macrophages stimulated by various
products (up to 2%of their total biosynthesis)
suggest that TNFa is an important mediator of
LPS-induced in￿ammatory response.17 Gluco-
corticoids such as dexamethasone inhibit the
production of circulating TNFa in mice, rats18
and guinea-pigs19 treated with LPS. Dexametha-
sone also alters the phagocytic functions of
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protect rat macrophages against LPS-induced
TNFa production in vitro, even though less so
in vivo.21
The cutaneous air pouch provides a virtual
cavity which can be tailored as a migration
chamber covered innerly with a lining mem-
brane, the facsimile synovium.22 Since the walls
of the pouch are formed by macrophages and
￿broblasts and a few mastocytes, we took
advantage of this model to study the mode of
action of LPS. Because of the potential damage
engendered by the neutrophil towards connec-
tive tissue,23 we investigated the dependency of
LPS-induced neutrophil emigration upon resi-
dent cells and bring evidence that macrophages
and TNFa are respectively the target and the
mediator of neutrophil recruitment following
LPSinjection into rat air pouches.
Materials and Methods
Animals
Brown-Norway rats (200±250 g) (Iffa Credo,
France) were allowed to take food and drink ad
libitum at room temperature.
Rat air pouch
The air pouch was induced according to
Edwards et al. 22 At day 0, rats were anaesthe-
tized with ketamine (50 mg/kg, i.m.) and their
dorsum was thoroughly shaved and gently
disinfected with ethanol 708 . Syringes and
needles were one-purpose material. Twenty ml
of sterile air taken under a laminar ￿ux hood
were injected subcutaneously with a gauge
26G3 0.5"; 0·45 3 12 needle; thus, disruption
of the underlying cutaneous connective tissue
allowed to make an air-full cavity. At day 5,
10 ml of sterile air were injected in similar
conditions in order to maintain pouch pa-
tency. At day 7, the pouches were injected
with LPS (2- 2000 ng/ml) under a volume of
1 ml. Control animals were injected with the
same volume of the LPS vehicle, i.e. phos-
phate buffered saline (PBS) without Ca2+ nor
Mg2+.
Neutrophil migration assessment
At various times (2 h, 24 h, 48 h and 96 h) after
LPS injection, animals were killed with an over-
dose of sodium penthiobarbitone. Four ml of
heparinized PBS solution (5 IU/ml) were in-
jected into the pouch in order to wash the
cavity by a gentle massage. The washing solu-
tion which was recovered at over 95% was
collected into 6 ml-polypropylene round bottom
tubes (Falcon8 2063, sterile/gamma irradiated)
stored on an ice bath.
Injection of the mastocyte degranulating
agent compound 48/80, under 1 ml (250
mg/ml) into the rat air pouch followed the same
procedures. This concentration was chosen for
its ability to induce granulocyte in￿ltration in
the mouse skin.24
Leukocyte and differential counts were per-
formed with a cell counter (Coulter©) and a
Cytospin (Hettich Universal©), respectively, and
allowed to calculate the total number of leuko-
cyte neutrophils recovered.
One ml aliquots prepared from the pouch
washing were centrifuged (400 g, 10 min at
48 C), pellets and aliquoted supernatants being
kept at - 408 Cuntil further analysis.
TNFa assay
TNFa production was determined directly in
the supernatant using the TNFa sensitive cell
line WEHI-164. Cells were plated out in 96-well
plates (8 3 104 cells/50 ml/well) and the sam-
ples (50 ml/well) or the human recombinant
TNFa (hr-TNFa) standards (1- 106 U/ml
hr-TNFa, 50 ml/well) were added. After 24 h
incubation (378 C, 7.5%CO2), MTT (tetrazolium
salt, Sigma, USA) was added (0·125 mg/well).
After an incubation of 4 h, the cells were lysed
with buffer (20% sodium dodecyl sulphate
(SDS) in 50% N,N-dimethylformamide (DMF),
pH4.7, 100 ml/well) for 18 h. The difference of
absorbances measured at 550 nm and 630 nm
with an ELISA reader (Dynatech MR5000)
allowed to evaluate the TNFa-like activity.
Modulation of neutrophil recruitment
In some experiments, cycloheximide (6 ng/ml)
or dexamethasone (0·5- 5 mg/ml) were injected
into the pouch 2 h before LPS (200 ng/ml)
under a volume of 1 ml. In other experiments,
animals received mepyramine (1- 4 mg/kg) i.p.
30±45 min before LPS was injected into the
pouch.
An anti-murine TNFa immunoglobulin pre-
paration was prepared as follows. Female HY/
CR rabbits (2500 g; Charles River, St Aubin les
Elboeufs, France) were immunized at 2 weeks
intervals by three injections of reduced murine
rTNFa (Immungenex, Los Angeles, CA, USA)
emulsi￿ed in adjuvant (Hunter Titermax; CytRx
Co., Norcross, Germany): the ￿rst one with
50 mg, the second and the third with 25 mg. The
animals were bled 2 weeks after the last injec-
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after precipitation with 40% saturation of am-
monium sulphate. Puri￿ed murine polyclonal
anti-TNFa (2·5 mg/ml) was administered into
the rat air pouches in a volume of 0.7 ml, 0.5h
before LPS. Control animals were treated under
same conditions with the same amounts of
preimmune immunoglobulins.
Macrophage replenishment
Rats were anaesthetized (sodium penthiobarbi-
tone, 60 mg/kg, i.p.), the trachea was cannu-
lated and broncho-alveolar lavages (BAL) with
sterile saline under a volume of 6 ml were
performed. This procedure was repeated until a
￿nal volume of 36 ml was obtained in a 50 ml-
polypropylene graduated conical tube (Falcon©
2098, Blue Max, sterile/gamma irradiated) on
ice bath. Immediately after centrifugation
(400 g, 5 min at 48 C), the cell suspension under-
went an hypotonic lysis with sterile water to
remove remaining erythrocytes. Then, cells
were counted (Counter Coulter©) and the
suspension was diluted to a ￿nal concentration
of 106 and 104 cells per ml. Purity and viability
were assessed by differential count and blue
trypan dye exclusion, respectively.
In other experiments, rats were treated with
cycloheximide i.p. (1 mg/kg, 0.5 ml).25 Control
animals received similar volumes of saline. After
2 h, the animals were sacri￿ced with an over-
dose of penthiobarbitone and both groups
underwent the same procedure to purify the
alveolar macrophages.
Liposome preparation and
experimental design
Multilamellar liposomes were prepared accord-
ing to Van Rooijen and Van Nieuwmegen.26 In
brief, 75 mg dipalmitoylphosphatidylcholine
and 11 mg cholesterol were dissolved in chloro-
form in a round bottom ￿ask. The thin ￿lm that
formed on the walls after rotary evaporation at
458 C was dispersed by gentle shaking for
10 min in 10 ml of PBS (pH 7.4), in order to
prepare empty liposomes, and in 10 ml of a
solution of 2 g clodronate (dichloromethylene
diphosphonate or Cl2MDP) in PBS, in order to
prepare liposomes with encapsulated Cl2MDP.
The preparation was kept for 2 h at room
temperature and sonicated four times for 5 min
at 458 Cin a waterbath (50 Hz) and kept at room
temperature for a further 2 h. Then, liposomes
were ￿ltered through 1.2-mm Minisart NML
￿lters (disposable syringe holders, sterile, pyro-
genfree, hydrophilic, Sartorius, Germany) centri-
fuged at 100000 g to 0.5 h, ￿nally resuspended
in 5 ml PBS and kept at 48 C.
Rats with 7-day-old air pouches were anaes-
thetized and injected into this preformed cavity
with either 0.3 ml liposome-encapsulated clo-
dronate or 0.3 ml liposome-encapsulated PBS
(empty liposome) for 96 h before LPS stimula-
tion as previously described.
In order to overcome the cell counter inabil-
ity to differentiate the remaining injected lipo-
somes and the LPS-recruited cells, 100 ml
aliquots of pouch washing were allowed to
stretch on glass slides by cytocentrifugation.
After a Diff-Quik® staining, the slides were
observed under light microscope at magni￿ca-
tion 3 1000. A differential leukocyte count was
performed (neutrophil, eosinophil, mono-
nuclear cell) taking account of the total ￿elds
observed. Thus, the data was expressed as the
number of neutrophils per ￿eld.
Materials
Lipopolysaccharide from Escherichia coli strain
O55: B5 was purchased from Difco (Detroit, MI,
USA); heparin from Choay (Paris, France); keta-
mine hydrochloride (KETALAR©) stored at 48 C
as a 100 mg/ml stock solution was from Parke-
Davis (Courbevoie, France); sodium penthiobar-
bitone was from Sano￿ Sante ´ Animale (Li-
bourne, France); compound 48/80, bovine
serum albumin, tetrazolium salt (MTT), the
histamine-receptor antagonist H1 pyrilamine
maleate (mepyramine), dexamethasone phos-
phate, chloroform, dipalmitoylphosphatidylcho-
line and cholesterol were from Sigma (St Louis,
MO, USA); PAF-receptor antagonist WEB 2170
was a kind gift of Boehringer Ingelheim (Ger-
many), cycloheximide was from Merck (Darm-
stadt, Germany); Diff-Quik® kit was purchased
from Baxter S.A. (Maurepas, France), clodronate
disodium salt (dichloromethylene diphospho-
nate, Cl2MDP) was a kind gift of Boehringer
Mannheim GmbH (Germany); murine recombi-
nant TNFa was purchased from Immungenex
(Los Angeles, CA, USA); human recombinant
TNFa was a kind gift of Dr G. R. Adolf (Wien,
Austria); WEHI-164 cells were a kind gift of Dr
I. L. Bonta (Rotterdam, The Netherlands).
Data analysis
Experimental value are given as mean SEM.
Statistical signi￿cance of differences between
two means of data were evaluated by a Stu-
dents’s t-test for unpaired observations and P-
values less than 0.05 were considered to be
signi￿cant.
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Dose-effect relationship induced by
LPS compared with compound 48/80
LPS (2±2000 ng, 2 h) induced a dose-dependent
leukocyte recruitment (Fig. 1a) which was
predominantly formed by neutrophils (LPS:
67 5·7% vs. control: 14·6 7·6% , P, 0·001,
n = 5- 7) (Fig. 1b). The threshold dose of LPS
for inducing a signi￿cant leukocyte in￿ltration
was 20 ng (P, 0·05, n = 7) which correlated
with the enhancement of the neutrophil popu-
lation at this dose (P, 0·01, n = 7). Since
leukocyte and neutrophil in￿ltration plateaued
at 200 ng, this dose was chosen for further
experiments. By contrast, compound 48/80
(250 mg, 2 h) failed to elicit leukocyte in￿ltra-
tion, compared with the vehicle.
Time-course of leukocyte and
neutrophil recruitment induced by
LPS
Leukocyte recruitment by LPS (200 ng) peaked
at 2 h and 24 h (Table 1) (P, 0·01, n = 7) and
was over at 48±96 h. Since at 2 h cell in￿ltra-
tion was predominantly constituted by neutro-
phils (Table 1) (P, 0·01, n = 7), this time
point was chosen for subsequent studies.
Detection of TNFa-like activity in
supernatants of pouch
Injected at the dose of 200 ng (2 h), LPS
induced the generation of a signi￿cant TNFa-
like activity detected in the pouch washings
(P, 0·01, n = 5- 9) under conditions where
compound 48/80 (250 mg/ml, 2 h) failed to do
so (Fig. 2).
Interference of dexamethasone with
LPS-induced neutrophil recruitment
and TNFa-like activity, failure of
mepyramine and WEB 2170
Injected 2 h before LPS, dexamethasone (50±
5000 ng) inhibited dose-dependently the LPS-
induced recruitment of neutrophils (P, 0·01
for the dose of 5000 ng, n = 7) (Fig. 3). Accord-
ingly, the threshold for inhibition was between
1000 and 2500 ng. By contrast, the H1-receptor
antagonist mepyramine (1 and 4 mg/kg, i.p.,
0.5h before LPS) and the PAF-receptor antago-
nist WEB 2170 (0.05 and 1 mg/kg, i.p., 0.5 h
before LPS) failed to interfere with the LPS-
induced recruitment of neutrophils (Tables 2
and 3).
Injected 2 h before LPS, dexamethasone
(5000 ng) also inhibited the generation of TNF-
alike activity (P, 0·05, n = 6) (Fig. 3, inset).
Table 1. Time-course of the LPS-induced leukocyte and neutrophil recruitment into
rat air pouches. Leukocyte and neutrophil recruitment was evaluated at different
time-points (2 h, 24 h, 48 h and 96 h) for the dose of 200 ng of LPS injected into the
air pouches under a volume of 1 ml. Results are expressed as mean SEM for
n= 5±7 experiments ( P , 0.01)
Time (h)
2 24 48 96
Leukocytes
(3 103 cells)
LPS 8500 1970 7500 700 1000 120 2730 60
Control 1990 370 3200 1300 1470 140 2500 680
Neutrophils
(3 103 cells)
LPS 7290 1840 1850 350 20 10 260 70
Control 300 180 310 160 0 250 150
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FIG. 1. Dose-dependent leukocyte and neutrophil recruit-
ment induced by LPS (j ) but not by compound 48/80 (s )
into rat air pouches. LPS, at the doses of 2, 20, 200, 2000 ng
was injected under a volume of 1 ml and samples removed
at 2 h. Compound 48/80 at the dose of 250mg and PBS was
tested under the same volume and at the same time-point.
Responses are for (a) leukocyte and (b) neutrophil recruit-
ment and are expressed as mean SEM of total number of
cells per pouch for leukocytes (n= 5±7) and neutrophils
(n = 5±7) in LPS-treated animals (j ) and in PBS-treated
animals (h ) ( P , 0.05, P , 0.01, P , 0.001).
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LPS-induced neutrophil recruitment
and generation of TNFa-like activity
Injected into the pouch at 6 ng, 2 h before
200 ng of LPS, cycloheximide inhibited signi￿-
cantly the LPS-induced neutrophil recruitment
(Fig. 4) (P, 0·01, n = 5), but it was inactive,
when injected together with LPS (P. 0·05,
n = 5). Similarly, cycloheximide interfered with
the TNFa-like activity generated by LPS (Fig. 4,
inset) (P, 0·05, n = 5).
Replenishment of cycloheximide-
treated pouches with alveolar
macrophage (AM) restores the LPS-
induced recruitment of neutrophils
and the accompanying generation of
TNFa-like activity
Alveolar macrophages (AM) (purity: 90% ; viabil-
ity: 95% ) were adjusted to a ￿nal concentration
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FIG. 2. Ability of LPS (200 ng, 2 h) and of compound 48/80
(250 mg, 2 h) to generate the TNFa-like activity in the rat air
pouch. The TNFa-like activity was evaluated for LPS and
compound 48/80 from the supernatants of pouch washing.
Results are expressed as mean SEM of TNFa-like activity
concentration for n= 4 in the PBS group (h ), n = 9 in the
LPS group (j ) and n = 5 in the compound 48/80 group ( ).
( P , 0.05, P , 0.01).
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FIG. 3. Effects of dexamethasone (DEX) injected into the rat
air pouches on neutrophil recruitment and TNF-a like
activity induced by LPS. DEX at the doses of 50, 500, 1000,
2500 and 5000 ng (j ) and the vehicle (0 ng) (h ) were tested
under a volume of 1 ml, 2 h before LPS (200 ng, 2 h).
Neutrophil responses are expressed as mean SEM of 5±7
animals per dose. TNF-a like activity (inset) was assessed
for the dose of 5 mg and expressed as mean SEM of TNF-
a like activity concentrations recovered in the air pouch
washing supernatants for 5 animals ( P , 0.05, P , 0.01).
Table 2. Failure of mepyramine on LPS-induced recruitment
of leukocytes and neutrophils into rat air pouches. The
effects of mepyramine (1 and 4 mg/kg, i.p., 0.5 h before
LPS) on neutrophil recruitment were evaluated for the dose
of 200 ng of LPS (2 h, into the pouches). Results are
expressed as mean SEM of total number of cells per
pouch for n = 5 experiments. No result was statistically
different from the control group
Mepyramine
(4 mg/kg)
Mepyramine
(1 mg/kg)
Control
(Saline)
Leukocytes
(3 103 cells)
5500 1400 8850 2690 5440 900
Neutrophils
(3 103 cells)
5070 1390 8820 2400 5080 880
Table 3. Failure of WEB 2170 to inhibit LPS-induced recruit-
ment of leukocytes and neutrophils into rat air pouches.
The effects of WEB 2170 (0.05 and 1 mg/kg, i.p., 0.5 h
before LPS) were evaluated for the dose of 200 ng of LPS
(2 h, into the pouches). Results (mean SEM of total num-
ber of cells per pouch, n= 5) of each single experiment are
reported. No result was statistically different from the
control LPS group
WEB 2170
(50 mg/kg)
WEB 2170
(1 mg/kg)
Control
(Saline)
Leukocytes
(3 103 cells)
10600 1230 11900 2600 10300 2800
Neutrophils
(3 103 cells)
7700 1760 8900 2800 8900 2400
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FIG. 4. Interference of cycloheximide(6 ng) injected into the
rat air pouch 2 h before LPS with both neutrophil recruit-
ment and TNF-a like activity. Cycloheximide was injected
under a volume of 1 ml with PBS, either 2 h before or
together with LPS (200 ng). Responses are for neutrophils
and TNF-a like activity (box). Results are expressed as mean
SEM of total number of cells per pouch (n = 5) for the
recruitment and of TNF-a like activity concentrations recov-
ered in the air pouch washing supernatants for n = 5.
Cycloheximide-treated animals, 2 h befere LPS (j ), together
with LPS ( ) and vehicle-treated animals (h ) ( P , 0.05,
P , 0.01).
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Macrophages and TNFa in rat air pouchesof 106 and 104 cells per ml and injected into
the air pouch previously treated with cyclohexi-
mide (6 ng per pouch, 2 h before). This replen-
ishment restored signi￿cantly the LPS-induced
neutrophil recruitment when compared with
cycloheximide-treated pouches or with PBS
stimulation (Fig. 5). In addition, replenishment
with 104 AMper ml from cycloheximide-treated
animals failed to support the LPS-induced
neutrophil recruitment (Fig. 6), contrasting to
AMfrom control animals (P, 0·001 for neutro-
phils, n = 6).
Replenishment with 106 AM/ml also restored
the generation by LPS of TNFa-like activity in
the pouch. Indeed, the replenished animals
generated 13·02 3 ng/ml of TNFa-like activity
upon LPS injection, whereas cycloheximide-
treated animals generated 2·4 2·4 ng/ml
(n = 5; P, 0·05) (Fig. 5, inset). By contrast,
replenishment with 104 AM/ml generated
4·06 0·4 ng/ml of TNFa-like activity, a value
not signi￿cant different from that obtained
with AM from cycloheximide-treated animals
(Fig. 6, inset).
Interference of liposome-
encapsulated clodronate with LPS-
induced neutrophil recruitment and
generation of TNFa-like activity in rat
air pouches
Liposome-encapsulated clodronate, injected into
the rat air pouches (300 ml, 96 h before LPS),
produced a marked inhibition of LPS-induced
neutrophil emigration (Fig. 7) and generation of
TNFa-like activity (Fig. 7, inset) in rat air
pouches, when compared with empty lipo-
somes (control: 57·1 11·9 neutrophils per
￿eld; 20·6 13 ng/ml TNFa-like activity;
treated: 10·3 1·7 neutrophils per ￿eld; 2·4
0·5 ng/ml TNFa-like activity; n = 5- 6, P,
0·01 and P, 0·01 respectively).
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FIG. 6. Effects of cycloheximide (CHX) (1 mg/kg, i.p. 2 h
before LPS) with the restoration of LPS-induced neutrophil
recruitment and of following replenishment with alveolar
macrophages in rat air pouches. Animals were treated with
CHX or its vehicle, i.p. for 2 h before bronchoalveolar
lavage. Replenishment was performed with 104 macro-
phages (1 ml) for 0.5 h, then LPS or PBS stimulation were
tested (200 ng, 2 h, 1 ml). Results are expressed as mean
SEM of total number of cells for n = 6 experiments for the
recruitment and of the TNFa-like activity (inset) recovered
in the air pouch washing supernatants for n = 6 under the
same conditions. Comparison was performed for CHX (j )
vs. its vehicle (h ) ( P , 0.01, P , 0.001).
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FIG. 5. Effects of replenishment with alveolar macrophages
on LPS-induced recruitment of neutrophils and TNF-a like
activity in rat air pouches. For the recruitment, air pouches
were pretreated with 6 ng of cycloheximide for 2 h, then
replenished with 106 macrophages for four animals or with
104 macrophages for six animals under a volume of 1 ml
for 0.5 h, then stimulated with LPS (200 ng) or PBS for 2 h
under a volume of 1 ml. Results are expressed as mean
SEM of total number of cells. For the TNF-a like activity
(inset), the same conditions were used and results are
expressed as mean SEM of this activity recovered in the
air pouch washing supernatants. Comparison for each
replenishment group was performed for LPS (j ) vs. PBS
(h ) ( P , 0.05, P , 0.01, P , 0.001).
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FIG. 7. Effects of liposome-encapsulated clodronate on
neutrophil recruitment and the TNF-a like activity triggered
by LPS in Brown Norway rat air pouches. Liposome-
encapsulated clodronate and empty liposomes were admin-
istered under a volume of 0.3 ml into the 7-day-old air
pouches, 96 h before LPS (200 ng, 2 h). Results are ex-
pressed as mean SEM of number of neutrophils per ® eld
(n = 6) and of the TNF-a like activity recovered in the air
pouch washing supernatants (n= 6) (inset). Comparison
was performed for liposome-encapsulated clodronate (j )
vs. empty liposome (h ) ( P , 0.01; P , 0.001).
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antibodies suppressed the LPS-
induced neutrophil recruitment and
the generation of TNFa-like activity in
rat air pouches
Under conditions where both LPS-induced
neutrophil recruitment and TNFa-like activity
were signi￿cantly inhibited by anti-mouse TNFa
polyclonal antibody (0.7 ml into the pouch,
0.5h before LPS), a treatment with non-immune
polyclonal antibodies was uneffective (control:
15611 4236 103 neutrophils vs. treated:
3888 411 103 neutrophils, P, 0·05 (Fig. 8);
control: 7·3 1·2 ng/ml of TNFa-like activity
vs. treated: 0·11 0·08 ng/ml of TNFa-like
activity, P, 0·01 (Fig. 8, inset; for n = 4 ani-
mals).
Discussion
The injection of LPS into the rat air pouch
resulted in a potent time- and dose-dependent
recruitment of neutrophils. Suppression of this
recruitment by low amounts of the protein
synthesis inhibitor cycloheximide and by dexa-
methasone, injected into the pouch, suggested
the involvement of a local target, capable of
producing a secondary mediator. Since the
concomitant injection of cycloheximide and LPS
failed to block neutrophil recruitment, the 2 h
interval required for inhibition is probably
accounted for by the time needed for inhibition
of protein synthesis. Alternatively, cyclohexi-
mide may induce apoptosis, 27,28 an active pro-
cess requiring protein and RNA synthesis29 and
involving the degradation of nuclear DNA.30
Although apoptosis is prevented in most cells
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FIG. 8. Effects of the mouse polyclonal anti-TNFa antibody
with neutrophil recruitment and TNFa-like induced by LPS.
Results are expressed as mean SEM of total number of
neutrophils per pouch and of TNFa-like activity concentra-
tions recovered in the air pouch washing supernatants. The
treated group received into their pouch 0.7 ml of the
polyclonal antibody for 0.5 h, then LPS (h ). The control
group was treated with a non-immune antibody preparation
under same conditions (j ). Results are expressed as mean
SEM of total number of cells for four experiments for the
recruitment and of the TNF-a like activity (inset) recovered
in the air pouch washing supernatants for four experiments.
Comparison was performed for treated group (j ) vs.
control group (h ) ( P , 0.05, P , 0.01).
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cytes,25,27 thymocytes and macrophages28 under-
go apoptosis when incubated with micromolar
doses of this drug. However, apoptosis is
unlikely to account for the suppression of
neutrophil recruitment in our experiments,
since the conditions used here (2 h, 6 ng
200 nmol) were previously shown not to induce
apoptosis.28
Resident mast cells might be affected by
cycloheximide and by dexamethasone during
LPS-induced neutrophil emigration, as suggested
by the results of Matsuda et al. 24 with murine
air blebs, a model closely resembling an air
pouch but lacking a facsimile synovium. Simi-
larly, Tannenbaum et al.,32 injected compound
48/80 into the rat skin at doses 50 times below
ours and provoked a marked neutrophilia with-
in 1±2 h. Compound 48/80 also caused mast
cell degranulation, neutrophil adhesion and
emigration into the cheek pouch vasculature.33
Nevertheless, mast cell involvement is unlikely
in our model, since the compound 48/80 failed
to induce a signi￿cant cell in￿ltration or genera-
tion of TNFa-like activity, throughout all time
intervals. A more likely hypothesis is that
￿broblasts and macrophages of the pouch lining
tissue account for the LPS-induced production
of chemotactic substances and the consequent
neutrophil recruitment, in agreement with the
anatomopathological studies of Edwards et al.22
T o verify to what extent this might apply to our
model, alveolar macrophages were used to
replenish the air pouch and indeed inhibition
by cycloheximide of neutrophil emigration and
generation of TNFa-like activity, was sur-
mounted by transferring fresh alveolar macro-
phages from control animals, whereas
macrophages from cycloheximide-treated ani-
mals were not effective, as reported.12,34 The
use of alveolar macrophages rather than other
sources of macrophages is supported by practi-
cal considerations concerning macrophage puri-
￿cation and their ability to provide large
amounts of TNFa
35 or chemoattractants such as
MIP-1a.36
Liposomes are particularly ef￿cient in deliver-
ing water-soluble drugs into phagocytic cells,
since phagocytosis is followed by phospho-
lipase-induced disruption of the liposome
phospholipid bilayers and the release of
entrapped drugs. In particular, liposome-
encapsulated clodronate which should deplete
air pouch macrophages37,38 reduced signi￿-
cantly LPS-induced neutrophil recruitment.
Since in separate experiments murine perito-
neal macrophages were still absent after 5 days
treatment (data not shown), the participation
of the air pouch macrophage during neutro-
phil emigration is thus likely. Clodronate is
speci￿c for macrophages, since it neither
affected the neutrophil population nor other
cell types.37,39,40
Since a potential role for histamine and PAFin
LPS-induced neutrophil recruitment into rat air
pouches was excluded by selective antagonists,
the effectiveness of cycloheximide and dexa-
methasone strongly suggests the involvement of
protein synthesis-dependent mediators such as
TNFa. As mentioned, the hypothesized partici-
pation of mast cells as a major source of
preformed TNFa
41 was ruled out by the failure
of compound 48/80 to induce neutrophil re-
cruitment and detectable TNFa-like activity.
Among cells that express the TNF gene, the
macrophage is unique, insofar as it is capable of
secreting-1000 times more TNFa in response to
LPS than any other cell type.42,43 Furthermore, a
TNFa-like activity was detected in the air pouch
transplanted with alveolar macrophages from
naive, but not from cycloheximide-treated ani-
mals. In addition, the rat alveolar macrophage
was shown to be an important producer of
chemoattractants when stimulated by LPS.44
T aken together, these results suggest that TNFa-
like activity accounts for the LPS-induced
neutrophil recruitment in our model. This was
supported by the ef￿cacy of an anti-murine
polyclonal TNFa antibody to abrogate both LPS-
triggered neutrophil recruitment and TNFa-like
activity. The resident macrophage is the likely
source of this cytokine, as its formation was
prevented by both in situ treatments with
liposome-encapsulated clodronate and polyclo-
nal antibody. Nevertheless, our results do not
clarify whether TNFa acts as a direct chemoat-
tractant to promote neutrophil emigration or if
an intermediary chemokine is required, such as
CINC/GRO or MIP-1 or 2. Indeed, even though
TNFa itself may increase adhesion molecules
such as CD11/18 to promote neutrophil
emigration,45 several studies seem to plead for a
chemokine networking involving either epithe-
lial cell46 or endothelial cell.47
In summary, we suggest that neutrophil re-
cruitment induced by LPS is a macrophage-
dependent event, involving the de novo synthe-
tized TNFa which act directly or via secondary
mediators.
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